Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > University of Glasgow Enhances Biomedical Engineering with NanoInk's DPN 5000 System: Will be used to develop and fabricate unique sensors for use in advanced diagnostic applications

Abstract:
NanoInk's NanoFabrication Systems Division is pleased to announce that the University of Glasgow's Biomedical Engineering Research Division (part of the school of engineering) has recently purchased and installed a DPN 5000 System - a dedicated, versatile instrument capable of patterning a variety of materials with nanoscale accuracy and precision. The NanoInk system will reside in the Advanced Medical Diagnostics research group, which plans to harness the power of the DPN 5000 System to create novel sensors for use in cutting edge diagnostics.

University of Glasgow Enhances Biomedical Engineering with NanoInk's DPN 5000 System: Will be used to develop and fabricate unique sensors for use in advanced diagnostic applications

Chicago, IL | Posted on October 17th, 2012

The Advanced Medical Diagnostics research group, led by Professor Jonathan Cooper, was established over 20 years ago. It has a strong track record in many aspects of bioengineering, especially those associated with advanced biomedical diagnostics, biosensors, cell engineering, lab-on-a-chip and bio-nanotechnology.

The DPN 5000 System is a full-featured tip-based lithography platform capable of multi-component deposition of a wide range of materials in sub-micron sized features. Its intuitive user interface enables the deposition of complex nanopatterns by precisely controlling tip movements during the writing process. DPN 5000 System users can easily design, create, and analyze nano and microstructures on a variety of substrates.

"With the acquisition of NanoInk's DPN 5000 system, we saw the opportunity to expand our already wide-ranging research capabilities with a state-of-the-art nanofabrication instrument," said Jonathan Cooper, Professor of Bioelectronics and Bioengineering, Dean of Graduate Studies. "The NanoInk platform will allow us to explore novel sensors and systems based around the combination of our micro and nano-engineered devices with complex molecular nanopatterns."

"We are delighted that the Biomedical Engineering Research Division at the University of Glasgow selected our DPN 5000 System," said Robert Marchmont, General Manager of NanoInk's NanoFabrication Systems Division, Europe, the Middle East and Africa. "With the DPN 5000 system, Professor Cooper and his team will be able to pioneer new micro and nano-engineered devices in support of their mission, which is the development of advanced diagnostics.

More information about the University of Glasgow's Advanced Medical Diagnostics research group is available at: www.gla.ac.uk/schools/engineering/research/divisions/biomedical/advancedmedicaldiagnosticsloac/.

NanoInk's NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory desktop in an easy to use and affordable platform. More information is available at:

www.nanoink.net/divisions.html#NanoFabrication. You can also follow NanoInk on Twitter at www.twitter.com/NanoInk, Facebook at www.facebook.com/nanoink.net, Google+ at www.gplus.to/nanoink, YouTube at www.youtube.com/user/nanoINKtv, and LinkedIn at www.linkedin.com/groups/Nano-Micro-Lithography-3791030/about?trk=anet_ug_grppro.

####

About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life sciences, engineering, pharmaceutical, and education industries. Using Dip Pen Nanolithography® (DPN®), a patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create micro-and nanoscale structures from a variety of materials on a range of substrates. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Headquartered in the Illinois Science + Technology Park, north of Chicago, NanoInk currently has several divisions including the NanoFabrication Systems Division, the Nano BioDiscovery Division, the NanoProfessor™ Division and the NanoGuardian™ Division. For more information on products and services offered by NanoInk, Inc., visit www.nanoink.net.

NanoInk, the NanoInk logo, Dip Pen Nanolithography, DPN, and NanoProfessor are registered trademarks of NanoInk, Inc.

For more information, please click here

Contacts:
Joshua Taustein
Associate
Dresner Corporate Services
20 N. Clark St. Suite 3550
Chicago, IL 60602
Direct: (312)780-7219
Mobile: (847)308-5168
www.dresnerpr.com

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Jobs

Could quantum technology be New Mexico’s next economic boon? Quantum New Mexico Coalition aims to establish state as national hub April 1st, 2022

SEMI Partners with GLOBALFOUNDRIES to Offer Apprenticeship Program Aimed at Building the Electronics Talent Pipeline August 11th, 2020

March 17th, 2020

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Sensors

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Groundbreaking precision in single-molecule optoelectronics August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Tools

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Turning up the signal November 8th, 2024

Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024

Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024

Nanobiotechnology

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024

New-Contracts/Sales/Customers

Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020

GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project